Skip to main content
Home
Toggle menu

  • Home

Bait and Switch? RFK Jr.’s FDA Pivots on ‘Promising’ Autism Treatment Leucovorin




Tue, 03/10/2026 - 15:15

Gizmodo

The FDA ultimately ruled against approving leucovorin for autism, citing a lack of "sufficient data."

Tags
health

Source
Bait and Switch? RFK Jr.’s FDA Pivots on ‘Promising’ Autism Treatment Leucovorin
sfy39587stp18